The latest news from academia, regulators
research labs and other things of interest
Posted: September 17, 2007
Peter Balbus to Speak at nanoTX'07 Nanotechnology Conference in Dallas, Texas
(Nanowerk News) Pragmaxis LLC, a Dallas-based business strategy and technology commercialization consulting firm, announced today that its founder and managing director Peter Balbus will be a featured speaker at the nanoTX'07 conference being held October 2-4, 2007 in Dallas, TX.
Balbus' presentation is titled "How Printed and Thin Film Electronics Technologies Will Drive Innovation in Biomedical Devices". He will emphasize where the current state of commercializeable technology is and where specific investable opportunities are likely to emerge over the next 2-5 years. He will also highlight how the convergence of formerly disparate disciplines including nanotech, biotech, physical chemistry, enzymes, materials science, ink-jet printing, genetics and information technology is driving real innovation in biomedical devices.
Balbus is a graduate of Massachusetts Institute of Technology with a degree in chemical engineering and has completed executive programs in strategy and finance at the University of Chicago. He has over 25 years of business strategy and technology commercialization experience. In addition to his paid consulting work he also donates time to non-profit organizations, most recently serving as Chapter Chair and President of the MIT Enterprise Forum of Chicago.
Balbus recently completed a major engagement with the Nanotech Institute at the University of Texas/Dallas where he assisted senior administration officers and scientists in defining technology commercialization strategy and policy. He also was actively involved in technology transfer and commercialization process development and negotiated licensing agreements with several external ventures on behalf of the university.
He is currently working with an active clientele that comprises a dynamic mix of executives and senior technologists in Fortune 500 corporations, privately-backed venture start-ups and research organizations.
In addition to his participation as a featured speaker at nanoTX'07, Balbus has also been appointed as the conference's Director of Grants & Awards, a volunteer position whose responsibilities include serving as emcee and host of an awards ceremony during nanoTX'07 and providing a point of contact for media relations. This role emphasizes the position of nanoTX'07 as the world's most watched nanotechnology event and a unique platform for other organizations to announce their grants and awards to audiences and media channels globally.
Organizations wishing to make global announcements of their own grants and awards programs are encouraged to contact nanoTX with their proposals. A selected few partners will be chosen to participate in the awards ceremonies at nanoTX'07 based on a combination of their alignment with the nanoTX'07 mission and the strength of their proposals.
About Pragmaxis LLC:
Pragmaxis LLC is a privately-held company that provides strategy, interim management, open innovation and technology commercialization services to Fortune 1000 corporations, new ventures, turn-arounds, universities and research labs. While the firm offers a broad base of experience in integrated business and technology strategy, it specializes in assisting clients understand and capture value from the converging disciplines of nanotechnology, biotechnology and enzyme chemistry and how this trend can be harnessed for sustainable competitive advantage and long-term profitability.
Founded in 1999, Pragmaxis LLC provides services to executives and senior technologists in a range of industries including: medical devices, pharmaceuticals, chemicals, consumer packaged goods, food & beverage, consumer electronics, energy and financial services.
nanoTX is the world's most comprehensive nanotechnology conference and exhibition. The event highlights advances in nanoscience, explains how nanotechnology is being used today and how it will impact a broad range of industries tomorrow, including: electronics, energy, aerospace, defense, biomedicine, robotics, chemicals and more.